HK1065954A1 - Preparation for determining pyrimidine metabolic capacity - Google Patents

Preparation for determining pyrimidine metabolic capacity

Info

Publication number
HK1065954A1
HK1065954A1 HK04108899A HK04108899A HK1065954A1 HK 1065954 A1 HK1065954 A1 HK 1065954A1 HK 04108899 A HK04108899 A HK 04108899A HK 04108899 A HK04108899 A HK 04108899A HK 1065954 A1 HK1065954 A1 HK 1065954A1
Authority
HK
Hong Kong
Prior art keywords
preparation
metabolic capacity
pyrimidine metabolic
determining pyrimidine
determining
Prior art date
Application number
HK04108899A
Other languages
English (en)
Inventor
Makoto Inada
Nobuhiro Ikei
Hideji Nonomura
Yasuo Irie
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of HK1065954A1 publication Critical patent/HK1065954A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0004Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806Suspensions, emulsions, colloids, dispersions
    • A61K49/1815Suspensions, emulsions, colloids, dispersions compo-inhalant, e.g. breath tests
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/24Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK04108899A 2001-03-13 2004-11-11 Preparation for determining pyrimidine metabolic capacity HK1065954A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001070828 2001-03-13
PCT/JP2002/002351 WO2002072153A1 (fr) 2001-03-13 2002-03-13 Agents permettant de mesurer la capacite de la pyrimidine a etre metabolisee

Publications (1)

Publication Number Publication Date
HK1065954A1 true HK1065954A1 (en) 2005-03-11

Family

ID=18928628

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04108899A HK1065954A1 (en) 2001-03-13 2004-11-11 Preparation for determining pyrimidine metabolic capacity

Country Status (12)

Country Link
US (2) US6797256B2 (es)
EP (1) EP1374911B1 (es)
JP (1) JPWO2002072153A1 (es)
KR (1) KR20030082973A (es)
CN (2) CN100341580C (es)
BR (1) BR0208007A (es)
CA (1) CA2440372C (es)
ES (1) ES2438728T3 (es)
HK (1) HK1065954A1 (es)
MX (1) MXPA03008343A (es)
TW (1) TWI239248B (es)
WO (1) WO2002072153A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060199269A1 (en) * 2005-03-07 2006-09-07 Schneider David R Method for assessing pyrimidine metabolism
CN101232905B (zh) * 2005-07-25 2013-01-09 大塚制药株式会社 一种用于测量嘧啶代谢能力的口服制剂
JP5213702B2 (ja) * 2006-04-13 2013-06-19 大塚製薬株式会社 ディスペプシア診断検査薬
KR102105354B1 (ko) 2012-08-20 2020-04-29 오츠카 세이야쿠 가부시키가이샤 당대사능의 측정 방법 및 그에 사용하는 조성물
ES2754246T3 (es) 2013-03-15 2020-04-16 Otsuka Pharma Co Ltd Composición para su uso en un método para medir la razón de combustión azúcar/ácido graso

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4328229A (en) * 1978-03-29 1982-05-04 Taiho Pharmaceutical Company Limited Anti-cancer composition for delivering 5-fluorouracil to cancer tissues
US5077034A (en) * 1990-03-30 1991-12-31 The President And Fellows Of Harvard College Treatment of tumors with 5-radioiodo-2'-deoxyuridine
US5248771A (en) * 1991-06-26 1993-09-28 Triumf Process for preparing no-carrier-added radiohalogenated vinyl nucleosides
US5670331A (en) * 1995-06-22 1997-09-23 The University Of Alabama Research Foundation Methods for optimizing fluoropyrimidine cancer therapy
US5707602A (en) 1996-03-25 1998-01-13 Meretek Diagnostics Measurement of gastric emptying
US5944670A (en) * 1996-12-02 1999-08-31 Oridion Medical Ltd. Breath test for the diagnosis of bacterial infection
AU745236B2 (en) * 1997-02-14 2002-03-14 George Washington University, The An assay for the measurement of DNA synthesis rates
IT1302026B1 (it) 1997-08-22 2000-07-20 Hoffmann La Roche Materiali immunologici e metodi per la rivelazione di diidropirimidinadeidrogenasi.

Also Published As

Publication number Publication date
JPWO2002072153A1 (ja) 2004-07-02
EP1374911A1 (en) 2004-01-02
TWI239248B (en) 2005-09-11
US20020132283A1 (en) 2002-09-19
KR20030082973A (ko) 2003-10-23
EP1374911B1 (en) 2013-10-16
CN101138638A (zh) 2008-03-12
US20040234452A1 (en) 2004-11-25
EP1374911A4 (en) 2007-06-20
ES2438728T3 (es) 2014-01-20
WO2002072153A1 (fr) 2002-09-19
BR0208007A (pt) 2004-03-02
CN1498116A (zh) 2004-05-19
MXPA03008343A (es) 2003-12-11
US6797256B2 (en) 2004-09-28
CN100341580C (zh) 2007-10-10
CA2440372C (en) 2009-09-15
CA2440372A1 (en) 2002-09-19

Similar Documents

Publication Publication Date Title
HK1070071A1 (en) New pyrimidine compounds
AU3576801A (en) Pyrimidine compounds
IL225893A0 (en) New triazolo pyrimidine compounds
IL162189A0 (en) Pyrimidine compounds
EP1374034A4 (en) ACCUMULATOR HIGH PRECISION
PL351690A1 (en) Pyrimidinone compounds
HK1089900A1 (en) Capacity management
EP1420469A4 (en) CELL
GB0116057D0 (en) Nano-electrochemical cells
EP1363637A4 (en) PYRIMIDINE COMPOUNDS AND METHOD FOR THE PRODUCTION AND USE THEREOF
HK1065954A1 (en) Preparation for determining pyrimidine metabolic capacity
GB0112802D0 (en) Pyrimidine derivatives
GB0112803D0 (en) Pyrimidine derivatives
GB2381945B (en) Cell
GB0119477D0 (en) Pyrimidine derivatives
AU2002238872B2 (en) Agents for measuring pyrimidine metabolizability
GB0103744D0 (en) Total evaporator
TW512746U (en) Skiing plate
AU2002238872A1 (en) Agents for measuring pyrimidine metabolizability
GB0119533D0 (en) Cell differentiation
GB0106329D0 (en) Cell differentiation
GB0119385D0 (en) Vapour-turbine condensation-droplet evaporator
HU0100326V0 (en) Standard change storage roller
GB0112808D0 (en) Pyrimidine derivatives
GB0119475D0 (en) Pyrimidine derivatives

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110313